基于MRI影像组学预测子宫内膜癌患者复发风险的模型开发与验证:一项多中心研究
本研究基于四个医疗中心421例经病理证实子宫内膜癌患者的临床病理因素和MRI影像组学特征,构建XGBoost分类器下的临床病理模型、影像组学模型及融合模型,用于预测复发风险。融合模型表现优于单一模型,其中基于瘤内区域的融合模型(FM(IA))在ROC、校准曲线和决策曲线分析中表现最优,高复发风险患者的无复发生存期较低风险患者更差。
要点
- 融合模型结合临床病理因素和影像组学特征,预测复发风险表现优于单独临床病理模型和影像组学模型。
- 基于瘤内区域的融合模型FM(IA)在ROC、校准曲线和决策曲线分析中表现最优。
- FM(IA)定义的高复发风险患者无复发生存期较低风险患者更差。
核心结论
- 整合瘤内影像组学特征和临床病理因素的融合模型(FM(IA))可能成为子宫内膜癌患者复发风险的有价值预测因子。
研究设计与样本
- 回顾性研究,纳入四个医疗中心421例经组织病理学证实的子宫内膜癌患者(101例复发 vs 320例未复发),分为训练组(n=235)、内部验证组(n=102)和外部验证组(n=84)。
诊断标准与关键数值
- 对每例患者从不同扩展区域分别提取1702个影像组学特征,采用极端梯度提升(XGBoost)分类器建立临床病理模型(CM)、影像组学模型(RM)和融合模型(FM);FM(IA)在各模型中预测复发风险表现最优,但融合模型性能随瘤周区域扩展呈下降趋势。
临床应用与阅片要点
- 作者认为基于所开发的FM(IA)对子宫内膜癌复发风险进行准确预测,可有助于制定个体化治疗决策并帮助避免治疗不足或过度治疗,从而改善患者预后。
- 影像组学特征从不同扩展区域分别提取,基于瘤内区域的融合模型表现最优,瘤周区域扩展时融合模型性能呈下降趋势。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a fusion model based on clinicopathological factors and MRI radiomics features for the prediction of recurrence risk in patients with endometrial cancer (EC).
METHODS: A total of 421 patients with histopathologically proved EC (101 recurrence vs. 320 non-recurrence EC) from four medical centers were included in this retrospective study, and were divided into the training (n = 235), internal validation (n = 102), and external validation (n = 84) cohorts. In total, 1702 radiomics features were respectively extracted from areas with different extensions for each patient. The extreme gradient boosting (XGBoost) classifier was applied to establish the clinicopathological model (CM), radiomics model (RM), and fusion model (FM). The performance of the established models was assessed by the discrimination, calibration, and clinical utility. Kaplan-Meier analysis was conducted to further determine the prognostic value of the models by evaluating the differences in recurrence-free survival (RFS) between the high- and low-risk patients of recurrence.
RESULTS: The FMs showed better performance compared with the models based on clinicopathological or radiomics features alone but with a reduced tendency when the peritumoral area (PA) was extended. The FM based on intratumoral area (IA) [FM (IA)] had the optimal performance in predicting the recurrence risk in terms of the ROC, calibration curve, and decision curve analysis. Kaplan-Meier survival curves showed that high-risk patients of recurrence defined by FM (IA) had a worse RFS than low-risk ones of recurrence.
CONCLUSIONS: The FM integrating intratumoral radiomics features and clinicopathological factors could be a valuable predictor for the recurrence risk of EC patients.
CLINICAL RELEVANCE STATEMENT: An accurate prediction based on our developed FM (IA) for the recurrence risk of EC could facilitate making an individualized therapeutic decision and help avoid under- or over-treatment, therefore improving the prognosis of patients.
KEY POINTS: • The fusion model combined clinicopathological factors and radiomics features exhibits the highest performance compared with the clinicopathological model and radiomics model. • Although higher values of area under the curve were observed for all fusion models, the performance tended to decrease with the extension of the peritumoral region. • Identifying patients with different risks of recurrence, the developed models can be used to facilitate individualized management.
引用
- Lin, Wang, Li, et al. Development and validation of MRI-based radiomics model to predict recurrence risk in patients with endometrial cancer: a multicenter study. Eur Radiol. 2023. PMID: 37171486. doi:10.1007/s00330-023-09685-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。